We collected information about Syndax Pharmaceuticals Inc Hours for you. Follow the liks to find out everything about Syndax Pharmaceuticals Inc Hours.
Syndax to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 15, 2021 11.04.21 Syndax Pharmaceuticals to Present Updated Data from SNDX-5613 and Axatilimab Clinical Programs During Oral Sessions at 63rd ASH Annual Meeting
https://www.nasdaq.com/market-activity/stocks/sndx/after-hours
Syndax Pharmaceuticals, Inc. Common Stock (SNDX) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.
https://www.barrons.com/market-data/stocks/sndx
Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352.
https://finance.yahoo.com/quote/SNDX
Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline …
https://www.nasdaq.com/market-activity/stocks/sndx
About Syndax Pharmaceuticals, Inc. 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3, WALTHAM, Massachusetts, 2451, United States +1 781 419-1400. Syndax Pharmaceuticals Inc …
https://finance.yahoo.com/news/avoid-syndax-pharmaceuticals-inc-sndx-210556569.html
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) was in 25 hedge funds' portfolios at the end of the second quarter of 2021. The all time high for this statistic is …
https://www.cnbc.com/quotes/sndx
Syndax Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing a pipeline of cancer therapies. The Company’s lead product candidates include SNDX-5613 and SNDX ...
https://www.barrons.com/market-data/stocks/sndx/research-ratings
Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352.
https://ir.syndax.com/news-releases/news-release-details/syndax-announces-positive-interim-data-demonstrating-robust
WALTHAM, Mass., April 20, 2021 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq:SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced updated positive data from the Phase 1 dose escalation portion of the ongoing Phase 1/2 AUGMENT-101 trial of …
https://www.marketwatch.com/investing/stock/sndx/analystestimates?mod=mw_quote_tab
Syndax Pharmaceuticals Inc. analyst estimates, including SNDX earnings per share estimates and analyst recommendations. ... After Hours Volume: 5.54K. Close Chg Chg % $17.98 : 0.01: 0.06%: Toggle ...
Searching for Syndax Pharmaceuticals Inc Hours?
You can just click the links above. The info is collected for you.
